annual CFI:
-$219.78M-$337.38M(-286.87%)Summary
- As of today (September 16, 2025), SNDX annual cash flow from investing activities is -$219.78 million, with the most recent change of -$337.38 million (-286.87%) on December 31, 2024.
- During the last 3 years, SNDX annual CFI has fallen by -$178.90 million (-437.70%).
- SNDX annual CFI is now -286.87% below its all-time high of $117.61 million, reached on December 31, 2023.
Performance
SNDX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$41.89M-$52.26M(-55.51%)Summary
- As of today (September 16, 2025), SNDX quarterly cash flow from investing activities is $41.89 million, with the most recent change of -$52.26 million (-55.51%) on June 30, 2025.
- Over the past year, SNDX quarterly CFI has dropped by -$19.86 million (-32.17%).
- SNDX quarterly CFI is now -55.51% below its all-time high of $94.14 million, reached on March 31, 2025.
Performance
SNDX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$46.10M-$19.86M(-75.71%)Summary
- As of today (September 16, 2025), SNDX TTM cash flow from investing activities is -$46.10 million, with the most recent change of -$19.86 million (-75.71%) on June 30, 2025.
- Over the past year, SNDX TTM CFI has dropped by -$32.23 million (-232.54%).
- SNDX TTM CFI is now -139.20% below its all-time high of $117.61 million, reached on December 31, 2023.
Performance
SNDX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SNDX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -286.9% | -32.2% | -232.5% |
| 3 y3 years | -437.7% | +183.9% | +38.6% |
| 5 y5 years | -1819.5% | +153.3% | +41.4% |
SNDX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -286.9% | at low | -55.5% | +115.6% | -139.2% | +79.0% |
| 5 y | 5-year | -286.9% | at low | -55.5% | +115.6% | -139.2% | +79.0% |
| alltime | all time | -286.9% | at low | -55.5% | +115.6% | -139.2% | +79.0% |
SNDX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $41.89M(-55.5%) | -$46.10M(+75.7%) |
| Mar 2025 | - | $94.14M(-135.0%) | -$26.23M(-88.1%) |
| Dec 2024 | -$219.78M(-286.9%) | -$268.97M(-409.7%) | -$219.78M(-767.8%) |
| Sep 2024 | - | $86.85M(+40.6%) | $32.91M(-337.4%) |
| Jun 2024 | - | $61.75M(-162.1%) | -$13.86M(+713.0%) |
| Mar 2024 | - | -$99.40M(+510.2%) | -$1.71M(-101.4%) |
| Dec 2023 | $117.61M(-163.2%) | -$16.29M(-140.6%) | $117.61M(-3253.1%) |
| Sep 2023 | - | $40.08M(-45.8%) | -$3.73M(-92.6%) |
| Jun 2023 | - | $73.91M(+271.1%) | -$50.60M(-71.0%) |
| Mar 2023 | - | $19.91M(-114.5%) | -$174.46M(-6.3%) |
| Dec 2022 | -$186.19M(+355.5%) | -$137.63M(+1926.0%) | -$186.19M(+71.6%) |
| Sep 2022 | - | -$6.79M(-86.4%) | -$108.52M(+44.5%) |
| Jun 2022 | - | -$49.95M(-710.5%) | -$75.09M(+2068.4%) |
| Mar 2022 | - | $8.18M(-113.6%) | -$3.46M(-91.5%) |
| Dec 2021 | -$40.87M(-71.3%) | -$59.96M(-325.1%) | -$40.87M(-9.3%) |
| Sep 2021 | - | $26.63M(+22.8%) | -$45.06M(-14.0%) |
| Jun 2021 | - | $21.68M(-174.2%) | -$52.41M(-65.7%) |
| Mar 2021 | - | -$29.23M(-54.4%) | -$152.71M(+7.1%) |
| Dec 2020 | -$142.53M(-1215.2%) | -$64.14M(-432.8%) | -$142.53M(+98.5%) |
| Sep 2020 | - | $19.27M(-124.5%) | -$71.79M(-8.8%) |
| Jun 2020 | - | -$78.61M(+312.6%) | -$78.70M(+313.7%) |
| Mar 2020 | - | -$19.05M(-388.9%) | -$19.02M(-248.8%) |
| Dec 2019 | $12.78M | $6.60M(-46.7%) | $12.78M(-42.3%) |
| Sep 2019 | - | $12.36M(-165.3%) | $22.15M(+66.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$18.93M(-248.5%) | $13.29M(-74.2%) |
| Mar 2019 | - | $12.75M(-20.1%) | $51.51M(+0.2%) |
| Dec 2018 | $51.40M(-401.1%) | $15.96M(+355.0%) | $51.40M(+39.0%) |
| Sep 2018 | - | $3.51M(-81.8%) | $36.99M(-8.4%) |
| Jun 2018 | - | $19.28M(+52.5%) | $40.40M(-361.6%) |
| Mar 2018 | - | $12.64M(+715.7%) | -$15.44M(-9.5%) |
| Dec 2017 | -$17.07M(-6.6%) | $1.55M(-77.6%) | -$17.07M(-708.4%) |
| Sep 2017 | - | $6.92M(-118.9%) | $2.81M(-28.7%) |
| Jun 2017 | - | -$36.56M(-431.9%) | $3.94M(-90.1%) |
| Mar 2017 | - | $11.01M(-48.6%) | $39.87M(-318.1%) |
| Dec 2016 | -$18.28M(-70.4%) | $21.43M(+166.2%) | -$18.28M(-54.0%) |
| Sep 2016 | - | $8.05M(-1390.1%) | -$39.71M(-16.9%) |
| Jun 2016 | - | -$624.00K(-98.7%) | -$47.76M(+1.3%) |
| Mar 2016 | - | -$47.14M(<-9900.0%) | -$47.14M(>+9900.0%) |
| Dec 2015 | -$61.67M(-3366.4%) | - | - |
| Dec 2014 | $1.89M(-146.9%) | - | - |
| Sep 2014 | - | $0.00(-100.0%) | -$64.00K(-11.1%) |
| Jun 2014 | - | $2.54M(+74.7%) | -$72.00K(-97.2%) |
| Mar 2014 | - | $1.45M(-135.8%) | -$2.61M(-35.8%) |
| Dec 2013 | -$4.03M(-915.2%) | -$4.05M(>+9900.0%) | -$4.06M(>+9900.0%) |
| Sep 2013 | - | -$8000.00(<-9900.0%) | -$8000.00(<-9900.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $494.00K(-77.5%) | - | - |
| Dec 2011 | $2.19M | - | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual CFI year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly CFI year-on-year change?
- What is Syndax Pharmaceuticals, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. TTM CFI year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual cash flow from investing activities?
The current annual CFI of SNDX is -$219.78M
What is the all time high annual CFI for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual cash flow from investing activities is $117.61M
What is Syndax Pharmaceuticals, Inc. annual CFI year-on-year change?
Over the past year, SNDX annual cash flow from investing activities has changed by -$337.38M (-286.87%)
What is Syndax Pharmaceuticals, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of SNDX is $41.89M
What is the all time high quarterly CFI for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly cash flow from investing activities is $94.14M
What is Syndax Pharmaceuticals, Inc. quarterly CFI year-on-year change?
Over the past year, SNDX quarterly cash flow from investing activities has changed by -$19.86M (-32.17%)
What is Syndax Pharmaceuticals, Inc. TTM cash flow from investing activities?
The current TTM CFI of SNDX is -$46.10M
What is the all time high TTM CFI for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high TTM cash flow from investing activities is $117.61M
What is Syndax Pharmaceuticals, Inc. TTM CFI year-on-year change?
Over the past year, SNDX TTM cash flow from investing activities has changed by -$32.23M (-232.54%)